BridgeMD
New treatment option for Generalized Anxiety Disorder (GAD)
Official title Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
ClinicalTrials.gov ID: NCT06846320
What this study is testing
What is ABBV-932?
ABBV-932 is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for generalized anxiety disorder (gad).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Generalized anxiety disorder (GAD) is usually treated with antidepressant therapy (ADT); however, sometimes ADTs alone are not enough to adequately treat GAD. The purpose of this study is to assess how safe and effective ABBV-932 is when added to the antidepressant therapies in adult participants with GAD who have had an inadequate response ADTs.
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Meet Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) criteria for generalized anxiety disorder (GAD)...
- Currently taking protocol-specified antidepressant therapies (ADT) for GAD with an inadequate response to an adequate dose (per label) and duration...
You likely can't join if
- Have a Montgomery-Åsberg Depression Rating Scale (MADRS) score \>= 20.
- New diagnosis or exacerbation of major depression in the last 6 months.
The study team makes the final eligibility decision.
Where it's taking place
- Huntsville, Alabama, United States
- Phoenix, Arizona, United States
- Tucson, Arizona, United States
- Anaheim, California, United States
- Colton, California, United States
- Imperial, California, United States
- Lemon Grove, California, United States
- Long Beach, California, United States
- Los Angeles, California, United States
- Oceanside, California, United States
- Temecula, California, United States
- Walnut Creek, California, United States
- Cromwell, Connecticut, United States
- Jacksonville, Florida, United States
- Largo, Florida, United States
- Maitland, Florida, United States
- Miami, Florida, United States
- Orlando, Florida, United States
- Marietta, Georgia, United States
- Savannah, Georgia, United States
+ 27 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Huntsville, Alabama, United States; Phoenix, Arizona, United States; Tucson, Arizona, United States; Anaheim, California, United States; Colton, California, United States; Imperial, California, United States and 41 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.